Mealey's (January 27, 2022, 12:17 PM EST) -- PHILADELPHIA — The Third Circuit U.S. Court of Appeals on Jan. 25 affirmed dismissal of stock-drop lawsuit involving a testosterone replacement therapy drug, finding that the plaintiff’s alleged wrongs against stockholders are “not actionable.”...